To test our hypothesis, we cocultured IHH hepatocytes with HT29 colorectal cancer cells followed by immunofluorescence co-staining for EMT and motility biomarkers, using vimentin [47] and actin-related protein 2/3 (ARP2/3) [32,48], respectively. This evidence concerns the gene VIM and colorectal cancer.